What Has Been the Progress and Growth of the Peptic Ulcer Market in Recent Years?
The peptic ulcer market has seen considerable growth due to a variety of factors.
• Recently, the market size for peptic ulcers has been experiencing consistent growth. Projections indicate that it will rise from $4.1 billion in 2024 to $4.24 billion in 2025, showing a compound annual growth rate (CAGR) of 3.5%.
Factors contributing to this increase during the historic period include a higher prevalence of helicobacter pylori infections, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), shifts in lifestyle and dietary practices, educational programs and awareness drives, along with an emphasis on managing stress.
What Is The Expected Growth In The Peptic Ulcer Market Size Evolve over the Forecast Period?
The peptic ulcer market is expected to maintain its strong growth trajectory in upcoming years.
• The future market size of peptic ulcers is estimated to grow consistently, with a projection to reach $4.91 billion by 2029 at a compound annual growth rate (CAGR) of 3.7%.
The projected growth during the forecast period can be credited to the development of new therapies and treatment methods, the rise in the elderly population, utilisation of precision medicine, prevention strategies and health improvement initiatives, as well as ongoing research and clinical trials. Key trends for the forecast period consist of the implementation of digital health solutions, enhancement in treatment procedures, growing instances of helicobacter pylori contamination, integration of diagnostic imaging technologies, and an increased inclination towards combination therapies.
What Main Forces Are Fueling Expansion In The Peptic Ulcer Market?
The peptic ulcer market is anticipated to grow due to the increasing occurrence of obesity. Characterized by an unhealthy accumulation of body fat leading to a body mass index (BMI) of 30 or more, obesity is a medical condition that can result from genes, environment, and lifestyle choices, such as inactive lifestyle and unhealthy eating habits. The excess body weight causes an overproduction of stomach acid, weakens the stomach's protective lining, and helps in the formation of peptic ulcers. Inflammation in the gut, prompted by obesity, can also lead to peptic ulcers. The Centers for Disease Control and Prevention reported in September 2024 that from August 2021 to August 2023, the percentage of adults suffering from obesity was 40.3%, with men accounting for 39.2% and women for 41.3%. Consequently, the escalating obesity rates contribute to the expansion of the peptic ulcer market.
Peptic Ulcer Market Driver: Peptic Ulcer Market Soars Due to Increased Smoking
What Are The Primary Segments In The Global Peptic Ulcer Market?
The peptic ulcer market covered in this report is segmented –
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce
Subsegments:
1) By Gastritis: Acute Gastritis, Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD
Pre-Book The Peptic Ulcer Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Peptic Ulcer Market?
To stay ahead in the peptic ulcer market, companies are creating novel products and solutions and getting them sanctioned by federal agencies. The role of drug development in controlling and treating peptic ulcers is pivotal; it assists with symptom management, healing, and prevention of complications while treating the root issue. For example, Akums Drugs and Pharmaceuticals Ltd., an Indian entity that specializes in pharmaceutical formulations and APIs, unveiled its latest product, Combikit, in April of 2023. This kit that consolidates Amoxicillin, Clarithromycin, and Esomeprazole got the nod from the Central Drugs Standard Control Organisation (CDSCO) for the treatment of Helicobacter pylori (H. pylori) associated duodenal ulcers and for wiping out H. pylori in patients with active or healed peptic ulcers. The treatment focusing on H. pylori has shown efficacy in dimming the chances of ulcer recurrence, providing substantial benefits to patients. H. pylori is an widespread infection in India that is tied up with gastritis and peptic ulcer development.
Who Are the Key Players In The Peptic Ulcer Market?
Major companies operating in the peptic ulcer market report are:
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• CSL Limited
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Company
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Hikma Pharmaceuticals PLC
• Zydus Lifesciences
• Lupin Limited
• Livzon Pharmaceutical Group Inc.
• Yuhan Corporation
• Torrent Pharmaceuticals Ltd.
• Daewoong Pharmaceutical Co. Ltd.
• Ilyang Pharmaceutical Co
• Jiangsu Carephar Pharmaceutical Co Ltd.
What Is The Most Dominant Region In The Peptic Ulcer Market?
North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
